SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (2363)12/20/2000 10:39:50 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
These Nature links are interesting:

Alzheimer's disease: Vaccination in a mouse model

A vaccine against Alzheimer's disease in humans is a long way off, but work reported this week shows that it could be a goal worth pursuing. Alzheimer's is characterized by the build-up of plaques of insoluble amyloid-beta (Ab) peptide in the brain. Using a new experimental protocol, researchers now show that, in mice genetically engineered to develop a form of Alzheimer's, the build up of plaques with age correlates with cognitive decline, a relationship that had until now eluded researchers. Furthermore, two groups report that a vaccination with Ab protects mice with Alzheimer's like pathology both from building up plaques and the loss of memory and learning ability associated with the progression of the disease.


nature.com

Let's see if ELN pops tomorrow. Kind of like one of those tests to see how deep a coma someone is in ...

le.ac.uk

Let's hope we get something more than a 3. <g>

Peter



To: Biomaven who wrote (2363)12/20/2000 11:14:06 PM
From: aknahow  Read Replies (1) | Respond to of 52153
 
Peter, just a quick question. When a company files an IND the FDA has 30 days to respond saying no trial can be begun.

What I would like to know is, does the FDA also notify a company that it can go ahead before the 30 day period has terminated? Or does the o.k. to proceed come mainly by receiving no negative response?

Any statistics on how many request for INDs are turned down.



To: Biomaven who wrote (2363)12/24/2000 12:40:28 AM
From: Scott H. Davis  Respond to of 52153
 
<<So not only did biotechs crunch today but we've acquired a "no brainer." <g> >> Peter, remember the scarecrow did OK with no brains.

Pay no attention to that bear behind the exchange curtains.

Scott